Inger Johansson

10.6k citations
134 papers · 8.3k · h-index 53

Impact in

  • Pharmacology top 0.01%
    • Pharmacogenetics and Drug Metabolism
    • Drug-Induced Hepatotoxicity and Protection
  • Biochemistry top 0.2%
    • Eicosanoids and Hypertension Pharmacology

Papers in

    • Pharmacogenetics and Drug Metabolism 65
    • Drug Transport and Resistance Mechanisms 19
    • Cancer Treatment and Pharmacology 11

Inger Johansson

129 papers receiving 7.9k citations

Peers

Inger Johansson
Comparison fields: 5 of 153
  • Pharmacology 4.6k
  • Biochemistry 852
  • Oncology 1.9k
  • Hepatology 381
  • Pathology and Forensic Medicine 752
Replace Jeffrey R. Idle with:
Jeffrey R. Idle United Kingdom
Michael T. Murray Australia
Olavi Pelkonen Finland
Miki Nakajima Japan
Robert H. Tukey United States
Hannu Raunio Finland
Tsuyoshi Yokoi Japan
Jürgen Brockmöller Germany
Yoshihiko Funae Japan
Thomas K. H. Chang Canada
Inger Johansson relative to Jeffrey R. Idle United Kingdom Jeffrey R. Idle's profile →
Citations per field
00.5×1.5×
Jeffrey R. Idle · 1×
Citations per year

Countries citing papers authored by Inger Johansson

Since Specialization
Citations

This map shows the geographic impact of Inger Johansson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inger Johansson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inger Johansson more than expected).

Fields of papers citing papers by Inger Johansson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inger Johansson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inger Johansson. The network helps show where Inger Johansson may publish in the future.

Co-authors

The 25 scholars most cited alongside Inger Johansson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Inger Johansson Line = papers co-authored together Inger Johansson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 134 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1994378
2 1996328
3 1988305
4 1995260
5 1984234
6 1999231
7 2003208
8 1993207
9 1985192
10 2010190
11 1997172
12 1992168
13 1988164
14 1988154
15 1999151
16 2001150
17 2018136
18 1997124
19 1999117
20 1992112

About Inger Johansson

Inger Johansson is a scholar working on Pharmacology, Oncology, Molecular Biology, Endocrinology, Diabetes and Metabolism and Physiology, having authored 134 papers that have together received 8.3k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (65 papers), Drug Transport and Resistance Mechanisms (19 papers), Alcohol Consumption and Health Effects (11 papers), Cancer Treatment and Pharmacology (11 papers), Metabolism and Genetic Disorders (9 papers), Liver physiology and pathology (7 papers), Eicosanoids and Hypertension Pharmacology (7 papers) and Adipose Tissue and Metabolism (6 papers). The work is most often cited by research in Pharmacology (4.6k citations), Biochemistry (852 citations), Oncology (1.9k citations), Hepatology (381 citations) and Pathology and Forensic Medicine (752 citations). Inger Johansson has collaborated with scholars based in Sweden, Netherlands and China. Frequent co-authors include Magnus Ingelman‐Sundberg, Leif Bertilsson, Folke Sjöqvist, Marja­‐Liisa Dahl, Erik Eliasson, Mikael Oscarson, Qun‐Ying Yue, Tommy B. Andersson, Åsa Nordling and Irene Persson. Their work appears in journals such as Biochemical and Biophysical Research Communications, European Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics, Journal of Biological Chemistry and Drug Metabolism and Disposition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact